An Acetylation Site in the Middle Domain of Hsp90 Regulates Chaperone Function

Scroggins, Bradley T., Robzyk, Kenneth, Wang, Dongxia, Marcu, Monica G., Tsutsumi, Shinji, Beebe, Kristin, Cotter, Robert J., Felts, Sara +4 more·2007·Molecular Cell
DOI 10.1016/j.molcel.2006.12.008

Cited by (421)

Items 201–300 of 421

  1. Acetylation of Lysine 92 Improves the Chaperone and Anti-apoptotic Activities of Human αB-Crystallin
    Rooban B. Nahomi, Rong Huang, Sandip Kumar Nandi, Benlian Wang, Smitha Padmanabha, Puttur Santhoshkumar, Sławomir Filipek, Ashis Biswas, Ram H. Nagaraj · 2013 · Biochemistry
  2. The unraveling of substrate specificity of histone deacetylase 6 domains using acetylome peptide microarrays and peptide libraries
    Zsófia Kutil, L. Skultetyova, David Rauh, Marat Meleshin, Ivan Šnajdr, Zora Nováková, Jana Mikesova, Jiřı́ Pavlı́ček, Martin Hadzima, Petra Baranová et al. · 2018 · The FASEB Journal
  3. Dynamically Shaping Chaperones. Allosteric Modulators of HSP90 Family as Regulatory Tools of Cell Metabolism in Neoplastic Progression
    Carlos Sànchez‐Martìn, Stefano Artin Serapian, Giorgio Colombo, Andrea Rasola · 2020 · Frontiers in Oncology
  4. Bromo-protopine, a novel protopine derivative, alleviates tau pathology by activating chaperone-mediated autophagy for Alzheimer’s disease therapy
    Sravan Gopalkrishnashetty Sreenivasmurthy, Ashok Iyaswamy, Senthilkumar Krishnamoorthi, Rambabu N. Reddi, Ananth Kumar Kammala, Karthick Vasudevan, Sanjib Senapati, Zhou Zhu, Cheng-Fu Su, Jia Liu et al. · 2022 · Frontiers in Molecular Biosciences
  5. Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia
    Siddhartha Ganguly, Trisha Home, Abdulraheem Yacoub, Suman Kambhampati, Huidong Shi, Prasad R. Dandawate, Subhash Padhyé, Ashok Kumar Saluja, Joseph P. McGuirk, Rekha Rao · 2015 · Oncotarget
  6. Radiosensitizing Potential of Epigenetic Anticancer Drugs
    Harlinde De Schutter, Sandra Nuyts · 2009 · Anti-Cancer Agents in Medicinal Chemistry
  7. The Co-Chaperone Hch1 Regulates Hsp90 Function Differently than Its Homologue Aha1 and Confers Sensitivity to Yeast to the Hsp90 Inhibitor NVP-AUY922
    Heather Armstrong, Annemarie Wolmarans, Rebecca Mercier, BaoChan Mai, Paul LaPointe · 2012 · PLoS ONE
  8. An inhibitor of histone deacetylase 6 activity, ACY-1215, reduces cAMP and cyst growth in polycystic kidney disease
    Murali K. Yanda, Qiangni Liu, Liudmila Cebotaru · 2017 · American Journal of Physiology-Renal Physiology
  9. Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Studies
    Nihal Abdelmoniem, Marwa Helmy Abdallah, Rua M. Mukhtar, Fatima Moutasim, Ahmed Rafie Ahmed, Alaa Edris, Walaa Ibraheem, Alaa A. Makki, E.M. Elshamly, Rashid I. Elhag et al. · 2023 · Molecules
  10. The Role of Sulfhydryl Reactivity of Small Molecules for the Activation of the KEAP1/NRF2 Pathway and the Heat Shock Response
    Albena T. Dinkova‐Kostova · 2012 · Scientifica
  11. Androgen receptor acetylation sites differentially regulate gene control
    Hortensia Faus, Bernard Haendler · 2007 · Journal of Cellular Biochemistry
  12. HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer
    Teru Hideshima, Ralph Mazitschek, Jun Qi, Naoya Mimura, Jen‐Chieh Tseng, Andrew L. Kung, James E. Bradner, Kenneth Carl Anderson · 2017 · Oncotarget
  13. Proteasome inhibitor-induced cleavage of HSP90 is mediated by ROS generation and caspase 10-activation in human leukemic cells
    Sangkyu Park, Jeong-A Park, Hwanmin Yoo, Han-Bum Park, Younghee Lee · 2017 · Redox Biology
  14. Simvastatin functions as a heat shock protein 90 inhibitor against triple‐negative breast cancer
    Xinhui Kou, Xiaoxiao Jiang, Huijuan Liu, Xuan Wang, Fanghui Sun, Jiami Han, Jiaxing Fan, Guize Feng, Zhaohu Lin, Lan Jiang et al. · 2018 · Cancer Science
  15. Role of Altered Expression, Activity and Sub-cellular Distribution of Various Histone Deacetylases (HDACs) in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis
    Arpna Srivastava, Jyotirmoy Banerjee, Vivek Dubey, Manjari Tripathi, Poodipedi Sarat Chandra, M. C. Sharma, Sanjeev Lalwani, Fouzia Siraj, Ramesh Sharanappa Doddamani, Aparna Banerjee Dixit · 2020 · Cellular and Molecular Neurobiology
  16. Thr90 phosphorylation of Hsp90α by protein kinase A regulates its chaperone machinery
    Xiaofeng Wang, Xin‐an Lu, Xiaomin Song, Wei Zhuo, Lin Jia, Yushan Jiang, Yongzhang Luo · 2011 · Biochemical Journal
  17. Mc1568 Inhibits Hdac6/8 Activity and Influenza a Virus Replication in Lung Epithelial Cells: Role of Hsp90 Acetylation
    Simona Panella, Maria Elena Marcocci, Ignacio Celestino, Sérgio Valente, Clemens Zwergel, Domenica Donatella Li Puma, Lucia Nencioni, Antonello Mai, Anna Teresa Palamara, Giovanna Simonetti · 2016 · Future Medicinal Chemistry
  18. Direct and/or Indirect Roles for SUMO in Modulating Alpha-Synuclein Toxicity
    Shamini Vijayakumaran, Mathew B. Wong, Helma Antony, Dean L. Pountney · 2015 · Biomolecules
  19. Histone Deacetylase Inhibitor Trichostatin A Enhances Antitumor Effects of Docetaxel or Erlotinib in A549 Cell Line
    Quncheng Zhang, Shujuan Jiang, Song Zhang, Xiaobin Ma · 2012 · Asian Pacific Journal of Cancer Prevention
  20. Recent Progress in CFTR Interactome Mapping and Its Importance for Cystic Fibrosis
    Sang Hyun Lim, Elizabeth-Ann Legere, Jamie D. Snider, Igor Štagljar · 2018 · Frontiers in Pharmacology
  21. Comparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluation
    Bohonowych, Jessica ES, Peng, Shuping, Gopal, Udhayakumar, Hance, Michael W, Wing, Shane B, Argraves, Kelley M, Lundgren, Karen, Isaacs, Jennifer S · 2011 · BMC Cancer
  22. LPS induces pp60 c-src -mediated tyrosine phosphorylation of Hsp90 in lung vascular endothelial cells and mouse lung
    Nektarios Barabutis, Vaishali Handa, Christiana Dimitropoulou, Ruslan Rafikov, Connie M. Snead, Sanjiv Kumar, Atul Joshi, Gagan Singh Thangjam, David J. Fulton, Stephen M. Black et al. · 2013 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  23. Acetylated α-Tubulin Regulated by N-Acetyl-Seryl-Aspartyl-Lysyl-Proline(Ac-SDKP) Exerts the Anti-fibrotic Effect in Rat Lung Fibrosis Induced by Silica
    Wang Xiaojun, Yan Liu, Hong Xu, Xianghong Zhang, Shifeng Li, Dingjie Xu, Gao Xuemin, Lijuan Zhang, Zhang Bonan, Wei Zhongqiu et al. · 2016 · Scientific Reports
  24. HDAC6-G3BP2 promotes lysosomal-TSC2 and suppresses mTORC1 under ETV4 targeting-induced low-lactate stress in non-small cell lung cancer
    Bei Liu, Jia-Xi Zhang, Xue Meng, Shelly M. Xie, F. Liu, Heli Chen, D. Yao, Ming-Lei Li, Minghui Guo, Hai-Tao Shen et al. · 2023 · Oncogene
  25. Phosphorylation-driven epichaperome assembly is a regulator of cellular adaptability and proliferation
    Tanaya Roychowdhury, Seth W. McNutt, Chiranjeevi Pasala, Hieu Thi Nguyen, Daniel T. Thornton, Sahil Sharma, Luke Botticelli, Chander Singh Digwal, Suhasini Joshi, Nan Yang et al. · 2024 · Nature Communications
  26. Novel Promising Antifungal Target Proteins for Conquering Invasive Fungal Infections
    Cheng Zhen, Hui Lu, Yuanying Jiang · 2022 · Frontiers in Microbiology
  27. Targeting Huntington’s disease through histone deacetylases
    Steven G. Gray · 2011 · Clinical Epigenetics
  28. Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis
    Véronique Birault, Roberto C. E. Solari, John W. Hanrahan, David Y. Thomas · 2013 · Current Opinion in Chemical Biology
  29. A highly selective Hsp90 affinity chromatography resin with a cleavable linker
    Philip F. Hughes, Jared James Barrott, David A. Carlson, David R. Loiselle, Brittany L. Speer, Khaldon Bodoor, Laurie A. Rund, Timothy Haystead · 2012 · Bioorganic & Medicinal Chemistry
  30. Non-histone substrates of histone deacetylases as potential therapeutic targets in epilepsy
    Sonali Kumar, Diksha Attrish, Arpna Srivastava, Jyotirmoy Banerjee, Manjari Tripathi, Poodipedi Sarat Chandra, Aparna Banerjee Dixit · 2020 · Expert Opinion on Therapeutic Targets
  31. HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
    Jie Wang, Feng Yun, Jiahui Sui, Wenpeng Liang, Dingding Shen, Qi Zhang · 2022 · Biomedicines
  32. Epigenetics and muscle dysfunction in chronic obstructive pulmonary disease
    Esther Barreiro, Joaquim Gea · 2014 · Translational research
  33. B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas
    Haijun Gu, Jia He, Yuzhan Li, Dazhao Mi, Tian Guan, Weikai Guo, Bo Liu, Yihua Chen · 2022 · Journal of Medicinal Chemistry
  34. Discovery of ErbB/HDAC inhibitors by combining the core pharmacophores of HDAC inhibitor vorinostat and kinase inhibitors vandetanib, BMS-690514, neratinib, and TAK-285
    Chao Ding, Dan Li, Yanwei Wang, Sai-Sai Han, Chunmei Gao, Chunyan Tan, Yuyang Jiang · 2017 · Chinese Chemical Letters
  35. The known unknowns of the Hsp90 chaperone
    Laura‐Marie Silbermann, Benjamin Vermeer, Sonja Schmid, Katarzyna M. Tych · 2024 · eLife
  36. Toward Isozyme-Selective Inhibitors of Histone Deacetylase As Therapeutic Agents for the Treatment of Cancer
    Sophia N. Ononye, Michael D. Van Heyst, Eric R. Falcone, Amy C. Anderson, Dennis L. Wright · 2012 · Pharmaceutical Patent Analyst
  37. Discovery and Mechanism of Natural Products as Modulators of Histone Acetylation
    Lilibeth A. Salvador, Hendrik Luesch · 2012 · Current Drug Targets
  38. Targeting histone deacetylase in thyroid cancer
    Diego Russo, Cosimo Durante, Stefania Bulotta, Cinzia Puppin, Efisio Puxeddu, Sébastiano Filetti, Giuseppe Damante · 2012 · Expert Opinion on Therapeutic Targets
  39. Psychiatric behaviors associated with cytoskeletal defects in radial neuronal migration
    Toshifumi Fukuda, Shigeru Yanagi · 2017 · Cellular and Molecular Life Sciences
  40. Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents
    Fengchao Lang, James A. Cornwell, Karambir Kaur, Omar Elmogazy, Wei Zhang, Meili Zhang, Hua Song, Zhonghe Sun, Xiaolin Wu, Mirit I. Aladjem et al. · 2023 · Neuro-Oncology
  41. The role of lysine acetylation in metabolic sensing and proteostasis
    Aziz Eftekhari, Usman Sabir, Takhar Kasumov · 2025 · Pharmacology & Therapeutics
  42. Hsp70 and Hsp90 post-translational modifications and translating the chaperone code
    Sarah J. Backe, Jennifer A. Heritz, Mehdi Mollapour · 2025 · Cell Stress and Chaperones
  43. Emerging Promise Of Epigenetics And Dna Methylation For The Diagnosis And Management Of Women‘S Cancers
    Allison Jones, Matthias Lechner, Evangelia-O Fourkala, Rebecca Sophie Kristeleit, Martin Widschwendter · 2010 · Epigenomics
  44. Indole-3-Acetic Acid Protects Against Lipopolysaccharide-induced Endothelial Cell Dysfunction and Lung Injury through the Activation of USP40
    Nargis Shaheen, Jiaxing Miao, Donna Li, Boyu Xia, Boina Baoyinna, Yutong Zhao, Jing Zhao · 2024 · American Journal of Respiratory Cell and Molecular Biology
  45. Oncogenic K-ras confers SAHA resistance by up-regulating HDAC6 and c-myc expression
    Qun Wang, Rong Tan, Xin Jian Zhu, Yi Zhang, Zhiping Tan, Bing Su, Yu Li · 2016 · Oncotarget
  46. TLN-4601, a novel anticancer agent, inhibits Ras signaling post Ras prenylation and before MEK activation
    Nadia Boufaied, My-Anh Wioland, Pierre Falardeau, Henriette Gourdeau · 2010 · Anti-Cancer Drugs
  47. Vorinostat enhances gefitinib‑induced cell death through reactive oxygen species‑dependent cleavage of HSP90 and its clients in non‑small cell lung cancer with the EGFR mutation
    Sang Gyu Park, Dong Kim, Mi Kyung Kim, Jee Lee, Jin Kyung Rho, Seong‐Yun Jeong, Eun Choi, Choung‐Soo Kim, Jung Sung Hwang · 2018 · Oncology Reports
  48. The Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases
    Richard J. Roberts, Logan Hallee, Chi Keung Lam · 2021 · Journal of Personalized Medicine
  49. Proteostasis Regulators in Cystic Fibrosis: Current Development and Future Perspectives
    Irene Brusa, Elvira Sondo, Federico Falchi, Nicoletta Pedemonte, Marinella Roberti, Andrea Cavalli · 2022 · Journal of Medicinal Chemistry
  50. A simple yeast-based system for analyzing inhibitor resistance in the human cancer drug targets Hsp90α/β
    Stefan H. Millson, Chrisostomos Prodromou, Peter W. Piper · 2010 · Biochemical Pharmacology
  51. Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
    Sangkyu Park, Jeong-A Park, Jae-Hyung Jeon, Younghee Lee · 2019 · Biomolecules & Therapeutics
  52. Suppressing migration and invasion of H1299 lung cancer cells by honokiol through disrupting expression of an HDAC6‐mediated matrix metalloproteinase 9
    Jih‐Tung Pai, Chia‐Yun Hsu, Yei‐San Hsieh, Tsung‐Yu Tsai, Kuo‐Tai Hua, Meng‐Shih Weng · 2020 · Food Science & Nutrition
  53. Histone Deacetylase 6–Controlled Hsp90 Acetylation Significantly Alters Mineralocorticoid Receptor Subcellular Dynamics But Not its Transcriptional Activity
    Rubén Jiménez-Canino, Fabián Lorenzo-Díaz, Frédéric Jaisser, Nicolette Farman, Teresa Giráldez, Diego Álvarez de la Rosa · 2016 · Endocrinology
  54. Design, synthesis and evaluation of novel ErbB/HDAC multitargeted inhibitors with selectivity in EGFRT790M mutant cell lines
    Lei Zhao, Tingting Fan, Zhichao Shi, Chao Ding, Cunlong Zhang, Zigao Yuan, Qinsheng Sun, Chunyan Tan, Bizhu Chu, Yuyang Jiang · 2021 · European Journal of Medicinal Chemistry
  55. Pnck induces ligand-independent EGFR degradation by probable perturbation of the Hsp90 chaperone complex.
    T. B. Deb, An-Nie H. Zuo, You-Hong Wang, Robert J. Barndt, A. Cheema, S. Sengupta, Christine M. Coticchia, M. Johnson · 2011 · American Journal of Physiology - Cell Physiology
  56. Positive or Negative Involvement of Heat Shock Proteins in Multiple Sclerosis Pathogenesis: An Overview
    G. Turturici, R. Tinnirello, G. Sconzo, A. Asea, G. Savettieri, P. Ragonese, F. Geraci · 2014 · Journal of Neuropathology and Experimental Neurology
  57. No stress – Hsp90 and signal transduction inLeishmania
    Antje Hombach, Joachim Clos · 2014 · Parasitology
  58. Functional Role and Hierarchy of the Intermolecular Interactions in Binding of Protein Kinase Clients to the Hsp90–Cdc37 Chaperone: Structure-Based Network Modeling of Allosteric Regulation
    Gabrielle Stetz, Gennady M. Verkhivker · 2018 · Journal of Chemical Information and Modeling
  59. HDAC6 Degrades nsp8 of Porcine Deltacoronavirus through Deacetylation and Ubiquitination to Inhibit Viral Replication
    Zhuang Li, Panpan Duan, Runhui Qiu, Liurong Fang, Puxian Fang, Shaobo Xiao · 2023 · Journal of Virology
  60. Middle domain of human Hsp90 isoforms differentially binds Aha1 in human cells and alters Hsp90 activity in yeast
    Kamil J. Synoradzki, Paweł Bieganowski · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  61. Lysine Acetylation is an Important Post-Translational Modification that Modulates Heat Shock Response in the Sea Cucumber Apostichopus japonicus
    Dongxue Xu, Xuan Wang · 2019 · International Journal of Molecular Sciences
  62. Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells
    Sangkyu Park, Jeong-A Park, Young-Eun Kim, Sukgil Song, Hyung‐Joo Kwon, Younghee Lee · 2014 · Cell Stress and Chaperones
  63. NBM-T-BBX-OS01, Semisynthesized from Osthole, Induced G1 Growth Arrest through HDAC6 Inhibition in Lung Cancer Cells
    Jih‐Tung Pai, Chia‐Yun Hsu, Kuo‐Tai Hua, Sheng-Yung Yu, Chung-Yang Huang, Chia-Nan Chen, Chiung‐Ho Liao, Meng‐Shih Weng · 2015 · Molecules
  64. Heat Shock Protein 90 and Role of Its Chemical Inhibitors in Treatment of Hematologic Malignancies
    Ngoc Anh Ho, Adam Y. Li, Shaoguang Li, Haojian Zhang · 2012 · Pharmaceuticals
  65. Histone deacetylase activity mediates acquired resistance towards structurally diverse HSP 90 inhibitors
    Ryan Chau Chia Chai, Jessica L. Vieusseux, Benjamin J. Lang, Chau H. Nguyen, Michelle M. Kouspou, Kara L. Britt, John T. Price · 2017 · Molecular Oncology
  66. Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid
    Kanagaraj Subramanian, Darren M. Hutt, Samantha M. Scott, Vijay R. Gupta, Shu Mao, William E. Balch · 2020 · Journal of Biological Chemistry
  67. Nucleotide exchange is sufficient for Hsp90 functions in vivo
    Michael J. Reidy, Kevin Garzillo, Daniel C. Masison · 2023 · Nature Communications
  68. Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity
    Mark R. Woodford, Michael Hughes, Rebecca Sager, Sarah J. Backe, Alexander J. Baker-Williams, Michael S. Bratslavsky, Joseph M Jacob, Oleg Shapiro, Michael L. Wong, Gennady Bratslavsky et al. · 2019 · Oncotarget
  69. Known and emerging factors modulating estrogenic effects of endocrine-disrupting chemicals
    Wanglong Zhang, Yu Luo, Li Zhang, Qian Cai, Xuejun Pan · 2013 · Environmental Reviews
  70. Protein Post-Translational Modifications in Plant Abiotic Stress Responses
    Gengmi Li, Baohua Feng, Qian‐Hao Zhu, Kaifeng Jiang, Tao Zhang · 2025 · Plants
  71. Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma
    Claudia Siebert, Denis Ciato, Masanori Murakami, Ludwig Frei‐Stuber, Luis Gustavo Perez‐Rivas, Jose Luis Monteserin Garcia, Svenja Nölting, Julian Maurer, Annette Feuchtinger, Axel Karl Walch et al. · 2019 · Frontiers in Endocrinology
  72. Proteins participating to the post-transcriptional regulation of the mitochondrial cytochrome c oxidase subunit IV via elements located in the 3′UTR
    Giuseppe Cannino, Elisa Ferruggia, Anna Maria Rinaldi · 2009 · Mitochondrion
  73. Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
    Matthew W. Lawless, Suzanne Norris, Kenneth John O'Byrne, Steven G. Gray · 2009 · Endocrine Metabolic & Immune Disorders - Drug Targets
  74. Honokiol from Magnolia spp. induces G1 arrest via disruption of EGFR stability through repressing HDAC6 deacetylated Hsp90 function in lung cancer cells
    Shiuan-Fu Liou, Kuo‐Tai Hua, Chia‐Yun Hsu, Meng‐Shih Weng · 2015 · Journal of Functional Foods
  75. Modulation of the Cochaperone AHA1 Regulates Heat-Shock Protein 90 and Endothelial NO Synthase Activation by Vascular Endothelial Growth Factor
    Fanny Desjardins, Chantal Delisle, Jean‐Philippe Gratton · 2012 · Arteriosclerosis Thrombosis and Vascular Biology
  76. The universe of Hsp90
    Marta Stankiewicz, Matthias P. Mayer · 2011 · BioMolecular Concepts
  77. Toxoplasma gondiiHsp90: potential roles in essential cellular processes of the parasite
    Sergio Oscar Angel, María J. Figueras, Maria Lis Alomar, Pablo C. Echeverría, Bin Deng · 2014 · Parasitology
  78. The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia
    Muhammad Rauzan, Charles T. H. Chuah, Tun Kiat Ko, S. Tiong Ong · 2017 · PLoS ONE
  79. Buxus alkaloid compound destabilizes mutant p53 through inhibition of the HSF1 chaperone axis
    Yuling Wang, Wei Wu, Yong-Nan Su, Zhipeng Ai, Han-Chuan Mou, Luo-Sheng Wan, Ying Luo, Ming‐Hua Qiu, Jihong Zhang · 2020 · Phytomedicine
  80. Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder
    Manuela Loi, Laura Gennaccaro, Claudia Fuchs, Stefania Trazzi, Giorgio Medici, Giuseppe Galvani, Nicola Mottolese, Marianna Tassinari, Roberto Rimondini, Andrea Milelli et al. · 2021 · International Journal of Molecular Sciences
  81. A Web of Possibilities: Network-Based Discovery of Protein Interaction Codes
    Daniel L. Winter, Melissa A. Erce, Marc Ronald Wilkins · 2014 · Journal of Proteome Research
  82. Hsp90 as a therapeutic target in patients with oesophageal carcinoma
    Simon Ekman, Michael Bergqvist, Roger Tell, Stefan N. Bergström, Johan Lennartsson · 2010 · Expert Opinion on Therapeutic Targets
  83. Comparison of the expression of 5 heat shock proteins in benign and malignant salivary gland tumor tissues
    Guilan Wang, Xiaolin Gu, LI CHEN, YINMEI WANG, Bin Cao, Qun E · 2013 · Oncology Letters
  84. Regulation of Tau Homeostasis and Toxicity by Acetylation
    Tara E. Tracy, Kathryn C. Claiborn, Li Gan · 2019 · Advances in experimental medicine and biology
  85. Impact of diabetes on alpha-crystallins and other heat shock proteins in the eye
    Erich A. Heise, Patrice Elie Fort · 2011 · Journal of ocular biology, diseases, and informatics
  86. The role of MicroRNAs in COPD muscle dysfunction and mass loss: implications on the clinic
    Esther Barreiro · 2016 · Expert Review of Respiratory Medicine
  87. Novel PRMT5-mediated arginine methylations of HSP90A are essential for maintenance of HSP90A function in NDRG2low ATL and various cancer cells
    Tomonaga Ichikawa, Obeid Shanab, Shingo Nakahata, Shunsuke Shimosaki, Nawin Manachai, Masaya Ono, Hidekatsu Iha, Kazuya Shimoda, Kazuhiro Morishita · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  88. Exploring Mechanisms of Allosteric Regulation and Communication Switching in the Multiprotein Regulatory Complexes of the Hsp90 Chaperone with Cochaperones and Client Proteins: Atomistic Insights from Integrative Biophysical Modeling and Network Analysis of Conformational Landscapes
    Gennady M. Verkhivker · 2022 · Journal of Molecular Biology
  89. Regulation of ERα Signaling Pathway in Neuronal HN10 Cells: Role of Protein Acetylation and Hsp90
    Tiina Suuronen, Johanna O. Ojala, Juha M. T. Hyttinen, Kai Kaarniranta, Anders Thornell, Sergiy Kyrylenko, Antero Salminen · 2008 · Neurochemical Research
  90. RETRACTED: Butein inhibits cancer cell growth by rescuing the wild-type thermal stability of mutant p53
    Bin Song, Jiajian Wang, Yixin Ren, Yong-Nan Su, Xueye Geng, Fan Yang, Hao Wang, Jihong Zhang · 2023 · Biomedicine & Pharmacotherapy · Retracted
  91. Multitarget Inhibitors Derived from Crosstalk Mechanism Involving VEGFR2
    Chao Ding, Cunlong Zhang, Mingli Zhang, Yu Chen, Chunyan Tan, Ying Tan, Yuyang Jiang · 2014 · Future Medicinal Chemistry
  92. Modulation of the Glucocorticoid Receptor Activity by Post-Translational Modifications
    Ana C. Liberman, María Antunica-Noguerol, EDUARDO S. ARZT · 2014 · Nuclear Receptor Research
  93. Phosphotyrosine Confers Client Specificity to Hsp90
    Matthias P. Mayer · 2010 · Molecular Cell
  94. HDAC6 deficiency or inhibition blocks FGFR3 accumulation and improves bone growth in a model of achondroplasia
    Sara Ota, Zi-Qiang Zhou, Megan P. Romero, Guang Yang, Peter J. Hurlin · 2016 · Human Molecular Genetics
  95. Interdisciplinary approaches for the discovery of novel antifungals
    Bonnie Yiu, Nicole Robbins, Leah E. Cowen · 2024 · Trends in Molecular Medicine
  96. Acetylation of the yeast Hsp40 chaperone protein Ydj1 fine-tunes proteostasis and translational fidelity
    Siddhi Omkar, Courtney Shrader, Joel R. Hoskins, Jake T. Kline, Megan M. Mitchem, Nitika Nitika, Luca Fornelli, Sue Wickner, Andrew W. Truman · 2024 · PLoS Genetics
  97. Histone Deacetylase: Therapeutic Targets in Retinal Degeneration
    Conor Daly, Jun Yin, Breandán N. Kennedy · 2015 · Advances in experimental medicine and biology
  98. A novel method for site-specific chemical SUMOylation: SUMOylation of Hsp90 modulates co-chaperone binding in vitro
    Annemarie Wolmarans, Allison Kwantes, Paul LaPointe · 2018 · Biological Chemistry
  99. Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion
    Kecheng Zhu, Yumei Zhang, Juan Zhang, Feiye Zhou, Linlin Zhang, Shushu Wang, Qin Zhu, Qianqian Liu, Xiao Wang, Libin Zhou · 2019 · Toxicology Letters
  100. Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation.
    T. B. Deb, Christine M. Coticchia, Robert J. Barndt, Hong Zuo, R. Dickson, M. Johnson · 2008 · American Journal of Physiology - Cell Physiology